Ryvu Therapeutics Statistics

Total Valuation

WSE:RVU has a market cap or net worth of PLN 552.57 million. The enterprise value is 540.79 million.

Market Cap	552.57M
Enterprise Value	540.79M

Important Dates

The next confirmed earnings date is Thursday, May 21, 2026.

Earnings Date	May 21, 2026
Ex-Dividend Date	n/a

Share Statistics

WSE:RVU has 23.12 million shares outstanding.

Current Share Class	19.07M
Shares Outstanding	23.12M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	20.02%
Owned by Institutions (%)	23.22%
Float	17.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	8.93
PS Ratio	6.30
PB Ratio	10.26
P/TBV Ratio	11.56
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.34
EV / Sales	6.17
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.45

Financial Position

The company has a current ratio of 2.26, with a Debt / Equity ratio of 1.78.

Current Ratio	2.26
Quick Ratio	2.07
Debt / Equity	1.78
Debt / EBITDA	n/a
Debt / FCF	-0.79
Interest Coverage	-11.04

Financial Efficiency

Return on equity (ROE) is -98.22% and return on invested capital (ROIC) is -270.37%.

Return on Equity (ROE)	-98.22%
Return on Assets (ROA)	-20.14%
Return on Invested Capital (ROIC)	-270.37%
Return on Capital Employed (ROCE)	-59.69%
Weighted Average Cost of Capital (WACC)	7.47%
Revenue Per Employee	384,662
Profits Per Employee	-443,987
Employee Count	228
Asset Turnover	0.29
Inventory Turnover	11.63

Taxes

In the past 12 months, WSE:RVU has paid 88,000 in taxes.

Income Tax	88,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.40% in the last 52 weeks. The beta is 0.59, so WSE:RVU's price volatility has been lower than the market average.

Beta (5Y)	0.59
52-Week Price Change	-22.40%
50-Day Moving Average	24.22
200-Day Moving Average	26.67
Relative Strength Index (RSI)	49.07
Average Volume (20 Days)	35,043

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, WSE:RVU had revenue of PLN 87.70 million and -101.23 million in losses. Loss per share was -4.38.

Revenue	87.70M
Gross Profit	72.90M
Operating Income	-97.21M
Pretax Income	-101.14M
Net Income	-101.23M
EBITDA	-87.99M
EBIT	-97.21M
Loss Per Share	-4.38

Full Income Statement

Balance Sheet

The company has 107.68 million in cash and 95.90 million in debt, giving a net cash position of 11.78 million or 0.51 per share.

Cash & Cash Equivalents	107.68M
Total Debt	95.90M
Net Cash	11.78M
Net Cash Per Share	0.51
Equity (Book Value)	53.83M
Book Value Per Share	2.33
Working Capital	77.67M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -114.10 million and capital expenditures -7.47 million, giving a free cash flow of -121.57 million.

Operating Cash Flow	-114.10M
Capital Expenditures	-7.47M
Depreciation & Amortization	9.22M
Net Borrowing	-3.05M
Free Cash Flow	-121.57M
FCF Per Share	-5.26

Full Cash Flow Statement

Margins

Gross margin is 83.12%, with operating and profit margins of -110.84% and -115.42%.

Gross Margin	83.12%
Operating Margin	-110.84%
Pretax Margin	-115.32%
Profit Margin	-115.42%
EBITDA Margin	-100.33%
EBIT Margin	-110.84%
FCF Margin	n/a

Dividends & Yields

WSE:RVU does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-18.32%
FCF Yield	-22.00%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

WSE:RVU has an Altman Z-Score of 0.35 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.35
Piotroski F-Score	2